Alzheimer's Disease Trial, By Invitation NCT06809725 Sponsor: Spark Neuro Inc. Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, By Invitation

NCT06809725
By Invitation Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are willing to sign and date a consent form agreeing to take part in the study.
  • People who are willing to follow all study procedures and are available for the full duration of the study.
  • People who are male or female, aged between 65 and 90 years old at the time of giving consent.
  • People who have a Salzburg Dementia Test Prediction (SDTP) score of 24 or higher (this is a cognitive screening score — confirm with trial site).
  • People who have someone in their life (an "informant") who is willing and able to answer questions about their thinking and memory, either in person or remotely.
  • People with no history of cognitive impairment (for the unimpaired group).
  • People who have a Salzburg Dementia Test Prediction (SDTP) score below 24 and are suspected of, or have been diagnosed with, a mild cognitive issue (for the mild cognitive impairment group).
  • People who have a Salzburg Dementia Test Prediction (SDTP) score below 24 and have been diagnosed with a moderate or severe cognitive issue (for the dementia group).
  • People who typically spend 2 or more hours per month with a study participant and are willing to provide information about that person's thinking and memory, either in person or remotely (for those joining as an "informant").

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are currently experiencing a skin condition on their scalp that could interfere with electrode contact placement, as judged by the person conducting the assessment.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Not Applicable
Sponsor
Spark Neuro Inc.
Registry
ClinicalTrials.gov
Start date
31 March 2025
Est. completion
1 April 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Accuracy of SPARK Cognitive Status Indicator compared to Adjudicated cognitive status; Sensitivity of SPARK Cognitive Status Indicator when identifying Alzheimer's disease in impaired subjects; Specificity of SPARK Cognitive Status Indicator when identifying Alzheimer's disease in impaired subjects

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov